Elevated cystatin C levels predict the incidence of vasospastic angina

Circulation Journal

Volumn 75, Issue 10, 2011, Pages 2439-2444

  Funayama, Akira ^a   Watanabe, Tetsu ^a   Tamabuchi, Toshiaki ^a   Otaki, Yoichiro ^a   Netsu, Shunsuke ^a   Hasegawa, Hiromasa ^a   Honda, Shintaro ^a   Ishino, Mitsunori ^a   Arimoto, Takanori ^a   Takahashi, Hiroki ^a   Shishido, Tetsuro ^a   Miyamoto, Takuya ^a   Nitobe, Joji ^a   Kubota, Isao ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Chronic kidney disease; Cystatin C; Vasospastic angina

Indexed keywords

ACETYLCHOLINE; C REACTIVE PROTEIN; CREATININE; CYSTATIN C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY SPASM; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INCIDENCE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; PROVOCATION TEST; TRIACYLGLYCEROL BLOOD LEVEL; VASOSPASTIC ANGINA;

AGED; ANGINA PECTORIS; BIOLOGICAL MARKERS; CORONARY VASOSPASM; CYSTATIN C; FEMALE; HUMANS; INCIDENCE; KIDNEY DISEASES; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 80053089521     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-0008     Document Type: Article

References (35)

1. Yasue H, Kugiyama K. Coronary spasm: Clinical features and pathogenesis. Intern Med 1997; 36: 760-765.
2. Pristipino C, Beltrame JF, Finocchiaro ML, Hattori R, Fujita M, Mongiardo R, et al. Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. Circulation 2000; 101: 1102-1108.
3. Nakagawa H, Morikawa Y, Mizuno Y, Harada E, Ito T, Matsui K, et al. Coronary spasm preferentially occurs at branch points: An angiographic comparison with atherosclerotic plaque. Circ Cardiovasc Interv 2009; 2: 97-104.
4. Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation 2005; 111: 3481-3488.
5. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-1695.
6. El Nahas M. Cardio-kidney-damage: A unifying concept. Kidney Int 2010; 78: 14-18.
7. Cerne D, Kaplan-Pavlovcic S, Kranjec I, Jurgens G. Mildly elevated serum creatinine concentration correlates with the extent of coronary atherosclerosis. Ren Fail 2000; 22: 799-808.
8. Zhang L, Zhao F, Yang Y, Qi L, Zhang B, Wang F, et al. Association between carotid artery intima-media thickness and early-stage CKD in a Chinese population. Am J Kidney Dis 2007; 49: 786-792.
9. Kawamoto R, Ohtsuka N, Kusunoki T, Yorimitsu N. An association between the estimated glomerular filtration rate and carotid atherosclerosis. Intern Med 2008; 47: 391-398.
10. Desbien AM, Chonchol M, Gnahn H, Sander D. Kidney function and progression of carotid intima-media thickness in a community study. Am J Kidney Dis 2008; 51: 584-593.
11. Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, et al. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med 2006; 145: 237-246.
12. Kiyosue A, Hirata Y, Ando J, Fujita H, Morita T, Takahashi M, et al. Plasma cystatin C concentration reflects the severity of coronary artery disease in patients without chronic kidney disease. Circ J 2010; 74: 2441-2447.
13. Iwanaga Y, Miyazaki S. Cystatin C in a high-risk combination. Circ J 2009; 73: 1593-1594.
14. Arimoto T, Takeishi Y, Niizeki T, Takabatake N, Okuyama H, Fukui A, et al. Cystatin C, a novel measure of renal function, is an independent predictor of cardiac events in patients with heart failure. J Card Fail 2005; 11: 595-601.
15. Muntner P, Mann D, Winston J, Bansilal S, Farkouh ME. Serum cystatin C and increased coronary heart disease prevalence in US adults without chronic kidney disease. Am J Cardiol 2008; 102: 54-57.
16. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005; 352: 2049-2060.
17. Jin Y, Moriya T, Tanaka K, Matsubara M, Fujita Y. Glomerular hyperfiltration in non-proteinuric and non-hypertensive Japanese type 2 diabetic patients. Diabetes Res Clin Pract 2006; 71: 264-271.
18. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-992.
19. Konta T, Hao Z, Abiko H, Ishikawa M, Takahashi T, Ikeda A, et al. Prevalence and risk factor analysis of microalbuminuria in Japanese general population: The Takahata study. Kidney Int 2006; 70: 751-756.
20. JCS Joint Working Group. Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) (JCS 2008): Digest version. Circ J 2010; 74: 1745-1762.
21. Itoh T, Mizuno Y, Harada E, Yoshimura M, Ogawa H, Yasue H. Coronary spasm is associated with chronic low-grade inflammation. Circ J 2007; 71: 1074-1078.
22. Miyao Y, Kugiyama K, Kawano H, Motoyama T, Ogawa H, Yoshimura M, et al. Diffuse intimal thickening of coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol 2000; 36: 432-437.
23. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann Intern Med 2001; 134: 629-636.
24. Koga S, Ikeda S, Nakata T, Yasunaga T, Takeno M, Koide Y, et al. Low glomerular filtration rate is associated with high prevalence of vasospastic angina. Circ J 2011; 75: 1691-1695.
25. Hsu CY, Chertow GM, Curhan GC. Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency. Kidney Int 2002; 61: 1567-1576.
26. Hallan S, de Mutsert R, Carlsen S, Dekker FW, Aasarød K, Holmen J. Obesity, smoking, and physical inactivity as risk factors for CKD: Are men more vulnerable? Am J Kidney Dis 2006; 47: 396-405.
27. Tsuchikura S, Shoji T, Shimomura N, Kakiya R, Emoto M, Koyama H, et al. Serum C-reactive protein and thioredoxin levels in subjects with mildly reduced glomerular filtration rate. BMC Nephrol 2010; 11: 7.
28. Vaziri ND, Navab M, Fogelman AM. HDL metabolism and activity in chronic kidney disease. Nat Rev Nephrol 2010; 6: 287-296.
29. Yamagishi M, Ito K, Tsutsui H, Miyazaki S, Goto Y, Nagaya N, et al. Lesion severity and hypercholesterolemia determine long-term prognosis of vasospastic angina treated with calcium channel antagonists. Circ J 2003; 67: 1029-1035.
30. Miwa K, Fujita M, Miyagi Y, Inoue H, Sasayama S. High-density lipoprotein cholesterol level and smoking modify the prognosis of patients with coronary vasospasm. Clin Cardiol 1995; 18: 267-272.
31. Miyamoto S, Kawano H, Sakamoto T, Soejima H, Kajiwara I, Hokamaki J, et al. Increased plasma levels of thioredoxin in patients with coronary spastic angina. Antioxid Redox Signal 2004; 6: 75-80.
32. Kugiyama K, Yasue H, Okumura K, Ogawa H, Fujimoto K, Nakao K, et al. Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation 1996; 94: 266-271.
33. Kugiyama K, Ohgushi M, Motoyama T, Sugiyama S, Ogawa H, Yoshimura M, et al. Nitric oxide-mediated flow-dependent dilation is impaired in coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol 1997; 30: 920-926.
34. Yilmaz MI, Saglam M, Caglar K, Cakir E, Sonmez A, Ozgurtas T, et al. The determinants of endothelial dysfunction in CKD: Oxidative stress and asymmetric dimethylarginine. Am J Kidney Dis 2006; 47: 42-50.
35. Yasue H, Mizuno Y, Harada E, Itoh T, Nakagawa H, Nakayama M, et al. Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calciumchannel blockers. J Am Coll Cardiol 2008; 51: 1742-1748.